Mission
THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY'S (PICI) MISSION IS TO ACCELERATE THE DEVELOPMENT OF BREAKTHROUGH IMMUNE THERAPIES TO TURN ALL CANCERS INTO CURABLE DISEASES.
Public Charity
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY, of SAN FRANCISCO, CA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $66.9M in revenue, $54.5M in expenses, $223.9M in total assets. 33 publicly reported grants to this organization, totaling roughly $303.6M, appear in IRS filings.
EIN: 473355381
SAN FRANCISCO, CA
Latest filing: 2024
Total Revenue$66.9M
Total Expenses$54.5M
Total Assets$223.9M
Grant Records33
Funding Total$303.6M
Filing Years2019–2024
Sample Grants Received
$40,000,000
MEDICAL / PUBLIC SERVICES
$3,000,000
HEALTH
$1,603,970
For grant recipient's exempt purposes
$845,680
$57,500
Showing up to 5 of 33 total records — full history available with membership.
Officers & Directors
DIRECTOR
Ben Horowitz
DIRECTOR
Bob Hugin
DIRECTOR
Bob Nelsen
DIRECTOR
Bob Pittman
DIRECTOR
Bruce Parker Phd
HEAD OF INTELLECTUAL PROPERTY
Christen Dipetrillo
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $66.9M | $54.5M | $223.9M |
| 2023 | $23.7M | $42.9M | $255.0M |
| 2022 | $32.8M | $62.2M | $307.2M |
| 2020 | $66.0M | $69.9M | $152.6M |
| 2019 | $162.6M | $78.0M | $159.3M |
Between 2019 and 2024, reported annual revenue declined from $162.6M to $66.9M (-59%), with total assets most recently reported at $223.9M.
Interactive year-over-year charts and full filing details available with membership.